Trump administration plans to end Medicare drug subsidies, raising seniors' premiums
The Trump administration intends to discontinue federal subsidies for Medicare Part D plans after 2026, which could push many seniors’ monthly prescription costs higher.
Trump administration officials disclosed that federal subsidies supporting Medicare Part D prescription plans will be terminated after 2026, ending billions in payments to insurers that help keep premiums low. Roughly 25 million seniors enrolled in Part D currently pay an average monthly premium of about $36, but the agency projects that 45 percent of them will face premium hikes of $11 to $20, another 30 percent will see increases of less than $10, and a quarter will experience no change.
The decision follows a recent increase in prices for around 700 drugs covered by Part D, which the administration attributes to the subsidy system encouraging higher rates. Officials claim alternative affordable options remain available, though critics note that many Americans are already burdened by rising living costs. The new rates will be announced to Medicare recipients in the fall, a timing that aligns with the midterm election cycle where health-care affordability is expected to be a prominent issue. President Donald Trump has previously asserted he would not cut Medicare funding, yet his broader budget proposal seeks to reduce the program’s budget by about $500 billion over eight years.
Why it matters
Seniors could face noticeably higher prescription drug bills, affecting household budgets and political debates on health-care costs.
How the sides frame it
LOW AGREEMENTLeft-leaning coverage emphasizes the harm to seniors and broken promises, centrist coverage frames the move as a political weapon for Democrats, while right-leaning coverage stresses fiscal necessity and labels the subsidy a bailout.
LEFT
The administration’s end of the Medicare drug subsidy is portrayed as a harmful cut that will raise seniors’ premiums and betray promises.
RIGHT
The termination is depicted as a cost-driven correction, portraying the subsidy as an unnecessary bailout of insurers.
The left emphasises
- raise seniors' premiums
- going to screw with seniors
- could see their prescription costs increase by hundreds of dollars
The right emphasises
- amid soaring costs
- keep premium increases under $10 for most seniors
- subsidy a “bailout” of big insurers
In this story